Pfizer vaccine: After Britain, this time India, Pfizer wants approval to use the vaccine! – First to do so, pfizer seeks Indian approval for covid vaccine

This time the digital desktop: The first step to winning the Covid war has already been found! Great Britain is the first country in the world to approve the Pfizer-Bioentech vaccine for the covid vaccine. The British government announced on Wednesday that a nationwide vaccination program would be launched next week. However, this program will be a priority. The Boris Johnson government has said that only people at risk will be vaccinated. This time, Pfizer India has also submitted an application for permission to import and market the vaccine in India. They have already submitted an application to the Comptroller General of Drugs of India. The agency has applied for permission to use the vaccine in India in case of emergency and has also applied for permission for clinical trials.

However, there are concerns about keeping the vaccine in India. This is because a cold chain of minus 60 degrees Celsius is needed to maintain this vaccine. Needless to say, the infrastructure is not in India. Even the price of ticks is high. Combining the two doses can cost around three lakhs. The price of a serum vaccine is one third. However, after Pfizer’s efficiency rate report came out, it was heard that testing of this ticker will start in India as well. They finally made that request.

Matt Hancock, Britain’s health secretary, tweeted last Wednesday: ‘Good news. Help is coming against Corona. The NHS (National Health Service) is set to start vaccination early next week. The Pfizer-Bioentech authorities are also pleased with the liquidation fair. “We said before that science would win,” said Albert Baurola, CEO of the company. The work progressed accordingly. Thanks to the Regulatory Agency for Medicines and Health Products (MAERA). They have played an important role in protecting the people of Great Britain. Many people have benefited from this authorization after extensive testing.

According to MAERA, the Pfizer-Bioentech vaccine is capable of up to 95 percent resistance against the coronavirus. After analyzing the final results of the latest trial, the company also claimed that there were no side effects from the corona vaccine they did. How does this vaccine work? Researchers have called it a new type of mRNA vaccine. According to them, this vaccine is capable of developing immunity in the body by taking small parts of the genetic code of the virus.

The Boris Johnson government has already ordered 40 million doses from the agency to vaccinate 20 million people in Britain. All will be vaccinated in two doses, according to official sources. In addition, the country’s Ministry of Health has said that 10 million doses will be available in the coming days. The British government has also drawn up a preliminary list of who will have priority in vaccination. The vaccine will be given first to healthcare and social care workers, including those over the age of 60, who are at risk for corona.

Read more: Gurung promises to win Mamata in Ekushey polls, returns to Dera after three years

After the first round of vaccinations, people over the age of 50 and those who already have health problems will be vaccinated next year. The second dose will be given 21 days after the first dose. The deadly virus continues to proliferate around the world. Outbreaks seem to be exacerbated in some places, but not quite. And that is why the whole world is waiting for the vaccine to arrive. Meanwhile, the authorization of the Pfizer vaccine is certainly a glimmer of hope.

This time digital is now also in telegrams. Subscribe, stay updated. Just click here.